id	sid	tid	token	lemma	pos
dpc-1293	1	1	dermatology	dermatology	NOUN
dpc-1293	1	2	:	:	PUNCT
dpc-1293	1	3	practical	practical	ADJ
dpc-1293	1	4	and	and	CCONJ
dpc-1293	1	5	conceptual	conceptual	ADJ
dpc-1293	1	6	dermatology	dermatology	NOUN
dpc-1293	1	7	practical	practical	ADJ
dpc-1293	1	8	&	&	CCONJ
dpc-1293	1	9	conceptual	conceptual	ADJ
dpc-1293	1	10	letter	letter	NOUN
dpc-1293	2	1	|	|	ADV
dpc-1293	2	2	dermatol	dermatol	ADJ
dpc-1293	2	3	pract	pract	NOUN
dpc-1293	2	4	concept	concept	NOUN
dpc-1293	2	5	.	.	PUNCT
dpc-1293	3	1	2021;11(2):e2021006	2021;11(2):e2021006	NUM
dpc-1293	3	2	1	1	NUM
dpc-1293	3	3	confluent	confluent	ADJ
dpc-1293	3	4	and	and	CCONJ
dpc-1293	3	5	reticulated	reticulated	ADJ
dpc-1293	3	6	papillomatosis	papillomatosis	NOUN
dpc-1293	3	7	associated	associate	VERB
dpc-1293	3	8	with	with	ADP
dpc-1293	3	9	obesity	obesity	NOUN
dpc-1293	3	10	:	:	PUNCT
dpc-1293	3	11	case	case	NOUN
dpc-1293	3	12	series	series	NOUN
dpc-1293	3	13	of	of	ADP
dpc-1293	3	14	three	three	NUM
dpc-1293	3	15	patients	patient	NOUN
dpc-1293	3	16	successfully	successfully	ADV
dpc-1293	3	17	treated	treat	VERB
dpc-1293	3	18	with	with	ADP
dpc-1293	3	19	oral	oral	ADJ
dpc-1293	3	20	 	 	SPACE
dpc-1293	3	21	doxycycline	doxycycline	NOUN
dpc-1293	3	22	maha	maha	PROPN
dpc-1293	4	1	lahouel1	lahouel1	PROPN
dpc-1293	4	2	,	,	PUNCT
dpc-1293	4	3	amina	amina	PROPN
dpc-1293	4	4	aounallah1	aounallah1	PROPN
dpc-1293	4	5	,	,	PUNCT
dpc-1293	4	6	sana	sana	PROPN
dpc-1293	4	7	mokni1	mokni1	PROPN
dpc-1293	4	8	,	,	PUNCT
dpc-1293	4	9	colandane	colandane	PROPN
dpc-1293	4	10	belajouza1	belajouza1	PROPN
dpc-1293	4	11	,	,	PUNCT
dpc-1293	4	12	mohamed	mohamed	PROPN
dpc-1293	4	13	denguezli1	denguezli1	PROPN
dpc-1293	4	14	1	1	NUM
dpc-1293	4	15	department	department	NOUN
dpc-1293	4	16	of	of	ADP
dpc-1293	4	17	dermatology	dermatology	NOUN
dpc-1293	4	18	,	,	PUNCT
dpc-1293	4	19	farhat	farhat	PROPN
dpc-1293	4	20	hached	hache	VERB
dpc-1293	4	21	university	university	NOUN
dpc-1293	4	22	hospital	hospital	NOUN
dpc-1293	4	23	,	,	PUNCT
dpc-1293	4	24	sousse	sousse	PROPN
dpc-1293	4	25	,	,	PUNCT
dpc-1293	4	26	tunisia	tunisia	PROPN
dpc-1293	4	27	key	key	ADJ
dpc-1293	4	28	words	word	NOUN
dpc-1293	4	29	:	:	PUNCT
dpc-1293	4	30	confluent	confluent	ADJ
dpc-1293	4	31	and	and	CCONJ
dpc-1293	4	32	reticulated	reticulated	ADJ
dpc-1293	4	33	papillomatosis	papillomatosis	NOUN
dpc-1293	4	34	,	,	PUNCT
dpc-1293	4	35	obesity	obesity	NOUN
dpc-1293	4	36	,	,	PUNCT
dpc-1293	4	37	treatment	treatment	NOUN
dpc-1293	4	38	,	,	PUNCT
dpc-1293	4	39	doxycycline	doxycycline	NOUN
dpc-1293	4	40	citation	citation	NOUN
dpc-1293	4	41	:	:	PUNCT
dpc-1293	5	1	lahouel	lahouel	PROPN
dpc-1293	5	2	m	m	PROPN
dpc-1293	5	3	,	,	PUNCT
dpc-1293	5	4	aounallah	aounallah	PROPN
dpc-1293	5	5	a	a	PRON
dpc-1293	5	6	,	,	PUNCT
dpc-1293	5	7	mokni	mokni	PROPN
dpc-1293	5	8	s	s	PROPN
dpc-1293	5	9	,	,	PUNCT
dpc-1293	5	10	belajouza	belajouza	PROPN
dpc-1293	5	11	c	c	NOUN
dpc-1293	5	12	,	,	PUNCT
dpc-1293	5	13	denguezli	denguezli	ADJ
dpc-1293	5	14	m.	m.	NOUN
dpc-1293	5	15	confluent	confluent	NOUN
dpc-1293	5	16	and	and	CCONJ
dpc-1293	5	17	reticulated	reticulated	ADJ
dpc-1293	5	18	papillomatosis	papillomatosis	NOUN
dpc-1293	5	19	associated	associate	VERB
dpc-1293	5	20	with	with	ADP
dpc-1293	5	21	obesity	obesity	NOUN
dpc-1293	5	22	:	:	PUNCT
dpc-1293	5	23	case	case	NOUN
dpc-1293	5	24	series	series	NOUN
dpc-1293	5	25	of	of	ADP
dpc-1293	5	26	three	three	NUM
dpc-1293	5	27	patients	patient	NOUN
dpc-1293	5	28	successfully	successfully	ADV
dpc-1293	5	29	treated	treat	VERB
dpc-1293	5	30	with	with	ADP
dpc-1293	5	31	oral	oral	ADJ
dpc-1293	5	32	doxycycline	doxycycline	NOUN
dpc-1293	5	33	.	.	PUNCT
dpc-1293	6	1	dermatol	dermatol	NOUN
dpc-1293	6	2	pract	pract	PROPN
dpc-1293	6	3	concept	concept	NOUN
dpc-1293	6	4	.	.	PUNCT
dpc-1293	7	1	2021;11(2):e2021006	2021;11(2):e2021006	X
dpc-1293	7	2	.	.	X
dpc-1293	7	3	doi	doi	NOUN
dpc-1293	7	4	:	:	PUNCT
dpc-1293	7	5	https://doi	https://doi	PROPN
dpc-1293	7	6	.	.	PUNCT
dpc-1293	7	7	org/10.5826	org/10.5826	NUM
dpc-1293	7	8	/	/	SYM
dpc-1293	7	9	dpc.1102a06	dpc.1102a06	NOUN
dpc-1293	7	10	accepted	accept	VERB
dpc-1293	7	11	:	:	PUNCT
dpc-1293	7	12	july	july	PROPN
dpc-1293	7	13	29	29	NUM
dpc-1293	7	14	,	,	PUNCT
dpc-1293	7	15	2020	2020	NUM
dpc-1293	7	16	;	;	PUNCT
dpc-1293	7	17	published	publish	VERB
dpc-1293	7	18	:	:	PUNCT
dpc-1293	7	19	april	april	PROPN
dpc-1293	7	20	12	12	NUM
dpc-1293	7	21	,	,	PUNCT
dpc-1293	7	22	2021	2021	NUM
dpc-1293	7	23	copyright	copyright	NOUN
dpc-1293	7	24	:	:	PUNCT
dpc-1293	8	1	©	©	PROPN
dpc-1293	8	2	2021	2021	NUM
dpc-1293	8	3	lahouel	lahouel	NOUN
dpc-1293	8	4	et	et	PROPN
dpc-1293	8	5	al	al	PROPN
dpc-1293	8	6	.	.	PUNCT
dpc-1293	9	1	this	this	PRON
dpc-1293	9	2	is	be	AUX
dpc-1293	9	3	an	an	DET
dpc-1293	9	4	open	open	ADJ
dpc-1293	9	5	-	-	PUNCT
dpc-1293	9	6	access	access	NOUN
dpc-1293	9	7	article	article	NOUN
dpc-1293	9	8	distributed	distribute	VERB
dpc-1293	9	9	under	under	ADP
dpc-1293	9	10	the	the	DET
dpc-1293	9	11	terms	term	NOUN
dpc-1293	9	12	of	of	ADP
dpc-1293	9	13	the	the	DET
dpc-1293	9	14	creative	creative	ADJ
dpc-1293	9	15	commons	common	NOUN
dpc-1293	9	16	attribution	attribution	NOUN
dpc-1293	9	17	license	license	NOUN
dpc-1293	9	18	by	by	ADP
dpc-1293	9	19	-	-	PUNCT
dpc-1293	9	20	nc-4.0	nc-4.0	NOUN
dpc-1293	9	21	,	,	PUNCT
dpc-1293	9	22	which	which	PRON
dpc-1293	9	23	permits	permit	VERB
dpc-1293	9	24	unrestricted	unrestricted	ADJ
dpc-1293	9	25	noncommercial	noncommercial	ADJ
dpc-1293	9	26	use	use	NOUN
dpc-1293	9	27	,	,	PUNCT
dpc-1293	9	28	distribution	distribution	NOUN
dpc-1293	9	29	,	,	PUNCT
dpc-1293	9	30	and	and	CCONJ
dpc-1293	9	31	reproduction	reproduction	NOUN
dpc-1293	9	32	in	in	ADP
dpc-1293	9	33	any	any	DET
dpc-1293	9	34	medium	medium	NOUN
dpc-1293	9	35	,	,	PUNCT
dpc-1293	9	36	provided	provide	VERB
dpc-1293	9	37	the	the	DET
dpc-1293	9	38	original	original	ADJ
dpc-1293	9	39	author	author	NOUN
dpc-1293	9	40	and	and	CCONJ
dpc-1293	9	41	source	source	NOUN
dpc-1293	9	42	are	be	AUX
dpc-1293	9	43	credited	credit	VERB
dpc-1293	9	44	.	.	PUNCT
dpc-1293	10	1	funding	funding	NOUN
dpc-1293	10	2	:	:	PUNCT
dpc-1293	10	3	none	none	NOUN
dpc-1293	10	4	.	.	PUNCT
dpc-1293	11	1	competing	compete	VERB
dpc-1293	11	2	interests	interest	NOUN
dpc-1293	11	3	:	:	PUNCT
dpc-1293	11	4	the	the	DET
dpc-1293	11	5	authors	author	NOUN
dpc-1293	11	6	have	have	VERB
dpc-1293	11	7	no	no	DET
dpc-1293	11	8	conflicts	conflict	NOUN
dpc-1293	11	9	of	of	ADP
dpc-1293	11	10	interest	interest	NOUN
dpc-1293	11	11	to	to	PART
dpc-1293	11	12	disclose	disclose	VERB
dpc-1293	11	13	.	.	PUNCT
dpc-1293	12	1	authorship	authorship	NOUN
dpc-1293	12	2	:	:	PUNCT
dpc-1293	12	3	all	all	DET
dpc-1293	12	4	authors	author	NOUN
dpc-1293	12	5	have	have	AUX
dpc-1293	12	6	contributed	contribute	VERB
dpc-1293	12	7	significantly	significantly	ADV
dpc-1293	12	8	to	to	ADP
dpc-1293	12	9	this	this	DET
dpc-1293	12	10	publication	publication	NOUN
dpc-1293	12	11	.	.	PUNCT
dpc-1293	13	1	corresponding	correspond	VERB
dpc-1293	13	2	author	author	NOUN
dpc-1293	13	3	:	:	PUNCT
dpc-1293	13	4	maha	maha	PROPN
dpc-1293	13	5	lahouel	lahouel	PROPN
dpc-1293	13	6	,	,	PUNCT
dpc-1293	13	7	md	md	PROPN
dpc-1293	13	8	,	,	PUNCT
dpc-1293	13	9	dermatology	dermatology	NOUN
dpc-1293	13	10	department	department	NOUN
dpc-1293	13	11	,	,	PUNCT
dpc-1293	13	12	fattouma	fattouma	PROPN
dpc-1293	13	13	bourguiba	bourguiba	PROPN
dpc-1293	13	14	university	university	PROPN
dpc-1293	13	15	hospital	hospital	NOUN
dpc-1293	13	16	,	,	PUNCT
dpc-1293	13	17	sousse	sousse	PROPN
dpc-1293	13	18	,	,	PUNCT
dpc-1293	13	19	tunisia	tunisia	PROPN
dpc-1293	13	20	.	.	PUNCT
dpc-1293	14	1	email	email	NOUN
dpc-1293	14	2	:	:	PUNCT
dpc-1293	15	1	mahalahouel@gmail.com	mahalahouel@gmail.com	X
dpc-1293	15	2	introduction	introduction	NOUN
dpc-1293	15	3	confluent	confluent	ADJ
dpc-1293	15	4	and	and	CCONJ
dpc-1293	15	5	reticulated	reticulated	ADJ
dpc-1293	15	6	papillomatosis	papillomatosis	NOUN
dpc-1293	15	7	(	(	PUNCT
dpc-1293	15	8	crp	crp	NOUN
dpc-1293	15	9	)	)	PUNCT
dpc-1293	15	10	of	of	ADP
dpc-1293	15	11	gougerot	gougerot	NOUN
dpc-1293	15	12	and	and	CCONJ
dpc-1293	15	13	carteaud	carteaud	VERB
dpc-1293	15	14	is	be	AUX
dpc-1293	15	15	a	a	DET
dpc-1293	15	16	rare	rare	ADJ
dpc-1293	15	17	skin	skin	NOUN
dpc-1293	15	18	disorder	disorder	NOUN
dpc-1293	15	19	[	[	X
dpc-1293	15	20	1,2	1,2	NUM
dpc-1293	15	21	]	]	PUNCT
dpc-1293	15	22	.	.	PUNCT
dpc-1293	16	1	its	its	PRON
dpc-1293	16	2	pathogenesis	pathogenesis	NOUN
dpc-1293	16	3	remains	remain	VERB
dpc-1293	16	4	unclear	unclear	ADJ
dpc-1293	16	5	,	,	PUNCT
dpc-1293	16	6	which	which	PRON
dpc-1293	16	7	explains	explain	VERB
dpc-1293	16	8	the	the	DET
dpc-1293	16	9	multiplicity	multiplicity	NOUN
dpc-1293	16	10	of	of	ADP
dpc-1293	16	11	therapy	therapy	NOUN
dpc-1293	16	12	options	option	NOUN
dpc-1293	16	13	with	with	ADP
dpc-1293	16	14	variable	variable	ADJ
dpc-1293	16	15	results	result	NOUN
dpc-1293	16	16	[	[	X
dpc-1293	16	17	1	1	NUM
dpc-1293	16	18	]	]	PUNCT
dpc-1293	16	19	.	.	PUNCT
dpc-1293	17	1	herein	herein	NOUN
dpc-1293	17	2	,	,	PUNCT
dpc-1293	17	3	we	we	PRON
dpc-1293	17	4	describe	describe	VERB
dpc-1293	17	5	3	3	NUM
dpc-1293	17	6	cases	case	NOUN
dpc-1293	17	7	of	of	ADP
dpc-1293	17	8	crp	crp	NOUN
dpc-1293	17	9	,	,	PUNCT
dpc-1293	17	10	discuss	discuss	VERB
dpc-1293	17	11	its	its	PRON
dpc-1293	17	12	association	association	NOUN
dpc-1293	17	13	with	with	ADP
dpc-1293	17	14	obesity	obesity	NOUN
dpc-1293	17	15	,	,	PUNCT
dpc-1293	17	16	and	and	CCONJ
dpc-1293	17	17	report	report	VERB
dpc-1293	17	18	the	the	DET
dpc-1293	17	19	effectiveness	effectiveness	NOUN
dpc-1293	17	20	of	of	ADP
dpc-1293	17	21	doxycycline	doxycycline	NOUN
dpc-1293	17	22	in	in	ADP
dpc-1293	17	23	its	its	PRON
dpc-1293	17	24	treatment	treatment	NOUN
dpc-1293	17	25	.	.	PUNCT
dpc-1293	18	1	case	case	NOUN
dpc-1293	18	2	presentations	presentation	NOUN
dpc-1293	18	3	case	case	NOUN
dpc-1293	18	4	1	1	NUM
dpc-1293	18	5	:	:	PUNCT
dpc-1293	18	6	a	a	DET
dpc-1293	18	7	20	20	NUM
dpc-1293	18	8	-	-	PUNCT
dpc-1293	18	9	year	year	NOUN
dpc-1293	18	10	-	-	PUNCT
dpc-1293	18	11	old	old	ADJ
dpc-1293	18	12	woman	woman	NOUN
dpc-1293	18	13	presented	present	VERB
dpc-1293	18	14	with	with	ADP
dpc-1293	18	15	hypertrophic	hypertrophic	ADJ
dpc-1293	18	16	squamous	squamous	ADJ
dpc-1293	18	17	lesions	lesion	NOUN
dpc-1293	18	18	mainly	mainly	ADV
dpc-1293	18	19	localized	localize	VERB
dpc-1293	18	20	on	on	ADP
dpc-1293	18	21	the	the	DET
dpc-1293	18	22	trunk	trunk	NOUN
dpc-1293	18	23	that	that	PRON
dpc-1293	18	24	had	have	AUX
dpc-1293	18	25	been	be	AUX
dpc-1293	18	26	evolving	evolve	VERB
dpc-1293	18	27	for	for	ADP
dpc-1293	18	28	the	the	DET
dpc-1293	18	29	previous	previous	ADJ
dpc-1293	18	30	2	2	NUM
dpc-1293	18	31	years	year	NOUN
dpc-1293	18	32	.	.	PUNCT
dpc-1293	19	1	at	at	ADP
dpc-1293	19	2	presentation	presentation	NOUN
dpc-1293	19	3	,	,	PUNCT
dpc-1293	19	4	the	the	DET
dpc-1293	19	5	patient	patient	NOUN
dpc-1293	19	6	had	have	VERB
dpc-1293	19	7	a	a	DET
dpc-1293	19	8	body	body	NOUN
dpc-1293	19	9	mass	mass	NOUN
dpc-1293	19	10	index	index	NOUN
dpc-1293	19	11	(	(	PUNCT
dpc-1293	19	12	bmi	bmi	PROPN
dpc-1293	19	13	)	)	PUNCT
dpc-1293	19	14	of	of	ADP
dpc-1293	19	15	35.9	35.9	NUM
dpc-1293	19	16	(	(	PUNCT
dpc-1293	19	17	obesity	obesity	NOUN
dpc-1293	19	18	class	class	PROPN
dpc-1293	19	19	ii	ii	PROPN
dpc-1293	19	20	)	)	PUNCT
dpc-1293	19	21	.	.	PUNCT
dpc-1293	20	1	examination	examination	NOUN
dpc-1293	20	2	revealed	reveal	VERB
dpc-1293	20	3	brownish	brownish	ADJ
dpc-1293	20	4	,	,	PUNCT
dpc-1293	20	5	hyperkeratotic	hyperkeratotic	ADJ
dpc-1293	20	6	,	,	PUNCT
dpc-1293	20	7	confluent	confluent	ADJ
dpc-1293	20	8	papules	papule	NOUN
dpc-1293	20	9	with	with	ADP
dpc-1293	20	10	a	a	DET
dpc-1293	20	11	reticulated	reticulated	ADJ
dpc-1293	20	12	pattern	pattern	NOUN
dpc-1293	20	13	in	in	ADP
dpc-1293	20	14	the	the	DET
dpc-1293	20	15	periphery	periphery	NOUN
dpc-1293	20	16	affecting	affect	VERB
dpc-1293	20	17	mainly	mainly	ADV
dpc-1293	20	18	the	the	DET
dpc-1293	20	19	trunk	trunk	NOUN
dpc-1293	20	20	(	(	PUNCT
dpc-1293	20	21	figure	figure	NOUN
dpc-1293	20	22	1a	1a	NOUN
dpc-1293	20	23	)	)	PUNCT
dpc-1293	20	24	,	,	PUNCT
dpc-1293	20	25	the	the	DET
dpc-1293	20	26	neck	neck	NOUN
dpc-1293	20	27	and	and	CCONJ
dpc-1293	20	28	the	the	DET
dpc-1293	20	29	back	back	NOUN
dpc-1293	20	30	.	.	PUNCT
dpc-1293	21	1	a	a	DET
dpc-1293	21	2	biopsy	biopsy	NOUN
dpc-1293	21	3	demonstrated	demonstrate	VERB
dpc-1293	21	4	compact	compact	ADJ
dpc-1293	21	5	hyperkeratosis	hyperkeratosis	NOUN
dpc-1293	21	6	,	,	PUNCT
dpc-1293	21	7	acanthosis	acanthosis	NOUN
dpc-1293	21	8	,	,	PUNCT
dpc-1293	21	9	papillomatosis	papillomatosis	NOUN
dpc-1293	21	10	,	,	PUNCT
dpc-1293	21	11	and	and	CCONJ
dpc-1293	21	12	hyperpigmentation	hyperpigmentation	NOUN
dpc-1293	21	13	of	of	ADP
dpc-1293	21	14	the	the	DET
dpc-1293	21	15	basal	basal	ADJ
dpc-1293	21	16	layer	layer	NOUN
dpc-1293	21	17	.	.	PUNCT
dpc-1293	22	1	the	the	DET
dpc-1293	22	2	diagnosis	diagnosis	NOUN
dpc-1293	22	3	of	of	ADP
dpc-1293	22	4	crp	crp	PROPN
dpc-1293	22	5	was	be	AUX
dpc-1293	22	6	made	make	VERB
dpc-1293	22	7	.	.	PUNCT
dpc-1293	23	1	doxycycline	doxycycline	PROPN
dpc-1293	23	2	was	be	AUX
dpc-1293	23	3	initiated	initiate	VERB
dpc-1293	23	4	(	(	PUNCT
dpc-1293	23	5	100	100	NUM
dpc-1293	23	6	mg	mg	ADV
dpc-1293	23	7	daily	daily	ADV
dpc-1293	23	8	)	)	PUNCT
dpc-1293	23	9	.	.	PUNCT
dpc-1293	24	1	two	two	NUM
dpc-1293	24	2	months	month	NOUN
dpc-1293	24	3	later	later	ADV
dpc-1293	24	4	,	,	PUNCT
dpc-1293	24	5	the	the	DET
dpc-1293	24	6	patient	patient	NOUN
dpc-1293	24	7	was	be	AUX
dpc-1293	24	8	free	free	ADJ
dpc-1293	24	9	of	of	ADP
dpc-1293	24	10	cutaneous	cutaneous	ADJ
dpc-1293	24	11	lesions	lesion	NOUN
dpc-1293	24	12	(	(	PUNCT
dpc-1293	24	13	figure	figure	NOUN
dpc-1293	24	14	1b	1b	NUM
dpc-1293	24	15	)	)	PUNCT
dpc-1293	24	16	.	.	PUNCT
dpc-1293	25	1	the	the	DET
dpc-1293	25	2	patient	patient	NOUN
dpc-1293	25	3	’s	’s	PART
dpc-1293	25	4	skin	skin	NOUN
dpc-1293	25	5	condition	condition	NOUN
dpc-1293	25	6	was	be	AUX
dpc-1293	25	7	stable	stable	ADJ
dpc-1293	25	8	after	after	ADP
dpc-1293	25	9	1	1	NUM
dpc-1293	25	10	year	year	NOUN
dpc-1293	25	11	of	of	ADP
dpc-1293	25	12	follow	follow	NOUN
dpc-1293	25	13	-	-	PUNCT
dpc-1293	25	14	up	up	NOUN
dpc-1293	25	15	.	.	PUNCT
dpc-1293	26	1	case	case	NOUN
dpc-1293	26	2	2	2	NUM
dpc-1293	26	3	:	:	PUNCT
dpc-1293	26	4	a	a	DET
dpc-1293	26	5	21	21	NUM
dpc-1293	26	6	-	-	PUNCT
dpc-1293	26	7	year	year	NOUN
dpc-1293	26	8	-	-	PUNCT
dpc-1293	26	9	old	old	ADJ
dpc-1293	26	10	overweight	overweight	ADJ
dpc-1293	26	11	man	man	NOUN
dpc-1293	26	12	(	(	PUNCT
dpc-1293	26	13	bmi	bmi	X
dpc-1293	26	14	>	>	X
dpc-1293	26	15	25	25	NUM
dpc-1293	26	16	)	)	PUNCT
dpc-1293	26	17	presented	present	VERB
dpc-1293	26	18	with	with	ADP
dpc-1293	26	19	a	a	DET
dpc-1293	26	20	5	5	NUM
dpc-1293	26	21	-	-	PUNCT
dpc-1293	26	22	month	month	NOUN
dpc-1293	26	23	history	history	NOUN
dpc-1293	26	24	of	of	ADP
dpc-1293	26	25	asymptomatic	asymptomatic	ADJ
dpc-1293	26	26	lesions	lesion	NOUN
dpc-1293	26	27	on	on	ADP
dpc-1293	26	28	the	the	DET
dpc-1293	26	29	trunk	trunk	NOUN
dpc-1293	26	30	.	.	PUNCT
dpc-1293	27	1	on	on	ADP
dpc-1293	27	2	dermatologic	dermatologic	ADJ
dpc-1293	27	3	examination	examination	NOUN
dpc-1293	27	4	,	,	PUNCT
dpc-1293	27	5	there	there	PRON
dpc-1293	27	6	was	be	VERB
dpc-1293	27	7	a	a	DET
dpc-1293	27	8	reticular	reticular	ADJ
dpc-1293	27	9	network	network	NOUN
dpc-1293	27	10	of	of	ADP
dpc-1293	27	11	hyperpigmented	hyperpigmente	VERB
dpc-1293	27	12	papules	papule	NOUN
dpc-1293	27	13	and	and	CCONJ
dpc-1293	27	14	plaques	plaque	NOUN
dpc-1293	27	15	on	on	ADP
dpc-1293	27	16	the	the	DET
dpc-1293	27	17	anterior	anterior	ADJ
dpc-1293	27	18	region	region	NOUN
dpc-1293	27	19	of	of	ADP
dpc-1293	27	20	the	the	DET
dpc-1293	27	21	trunk	trunk	NOUN
dpc-1293	27	22	(	(	PUNCT
dpc-1293	27	23	figure	figure	NOUN
dpc-1293	27	24	2a	2a	NUM
dpc-1293	27	25	)	)	PUNCT
dpc-1293	27	26	.	.	PUNCT
dpc-1293	28	1	a	a	DET
dpc-1293	28	2	biopsy	biopsy	NOUN
dpc-1293	28	3	specimen	speciman	NOUN
dpc-1293	28	4	revealed	reveal	VERB
dpc-1293	28	5	hyperkeratosis	hyperkeratosis	NOUN
dpc-1293	28	6	,	,	PUNCT
dpc-1293	28	7	papillomatosis	papillomatosis	NOUN
dpc-1293	28	8	,	,	PUNCT
dpc-1293	28	9	and	and	CCONJ
dpc-1293	28	10	a	a	DET
dpc-1293	28	11	perivascular	perivascular	ADJ
dpc-1293	28	12	inflammatory	inflammatory	NOUN
dpc-1293	28	13	infiltrate	infiltrate	NOUN
dpc-1293	28	14	in	in	ADP
dpc-1293	28	15	the	the	DET
dpc-1293	28	16	dermis	dermis	NOUN
dpc-1293	28	17	with	with	ADP
dpc-1293	28	18	no	no	DET
dpc-1293	28	19	signs	sign	NOUN
dpc-1293	28	20	of	of	ADP
dpc-1293	28	21	fungal	fungal	ADJ
dpc-1293	28	22	infection	infection	NOUN
dpc-1293	28	23	,	,	PUNCT
dpc-1293	28	24	confirming	confirm	VERB
dpc-1293	28	25	the	the	DET
dpc-1293	28	26	diagnosis	diagnosis	NOUN
dpc-1293	28	27	of	of	ADP
dpc-1293	28	28	crp	crp	PROPN
dpc-1293	28	29	.	.	PUNCT
dpc-1293	29	1	within	within	ADP
dpc-1293	29	2	1	1	NUM
dpc-1293	29	3	month	month	NOUN
dpc-1293	29	4	of	of	ADP
dpc-1293	29	5	doxycycline	doxycycline	NOUN
dpc-1293	29	6	treatment	treatment	NOUN
dpc-1293	29	7	(	(	PUNCT
dpc-1293	29	8	100	100	NUM
dpc-1293	29	9	mg	mg	ADV
dpc-1293	29	10	daily	daily	ADV
dpc-1293	29	11	)	)	PUNCT
dpc-1293	29	12	,	,	PUNCT
dpc-1293	29	13	lesions	lesion	NOUN
dpc-1293	29	14	disappeared	disappear	VERB
dpc-1293	29	15	completely	completely	ADV
dpc-1293	29	16	,	,	PUNCT
dpc-1293	29	17	with	with	ADP
dpc-1293	29	18	no	no	DET
dpc-1293	29	19	relapse	relapse	NOUN
dpc-1293	29	20	during	during	ADP
dpc-1293	29	21	18	18	NUM
dpc-1293	29	22	month	month	NOUN
dpc-1293	29	23	-	-	PUNCT
dpc-1293	29	24	follow	follow	VERB
dpc-1293	29	25	-	-	PUNCT
dpc-1293	29	26	up	up	NOUN
dpc-1293	29	27	period	period	NOUN
dpc-1293	29	28	(	(	PUNCT
dpc-1293	29	29	figure	figure	NOUN
dpc-1293	29	30	2b	2b	NOUN
dpc-1293	29	31	)	)	PUNCT
dpc-1293	29	32	.	.	PUNCT
dpc-1293	30	1	case	case	NOUN
dpc-1293	30	2	3	3	NUM
dpc-1293	30	3	:	:	PUNCT
dpc-1293	30	4	a	a	DET
dpc-1293	30	5	16	16	NUM
dpc-1293	30	6	-	-	PUNCT
dpc-1293	30	7	year	year	NOUN
dpc-1293	30	8	-	-	PUNCT
dpc-1293	30	9	old	old	ADJ
dpc-1293	30	10	obese	obese	NOUN
dpc-1293	30	11	adolescent	adolescent	ADJ
dpc-1293	30	12	(	(	PUNCT
dpc-1293	30	13	bmi	bmi	X
dpc-1293	30	14	>	>	X
dpc-1293	30	15	35	35	NUM
dpc-1293	30	16	)	)	PUNCT
dpc-1293	30	17	presented	present	VERB
dpc-1293	30	18	with	with	ADP
dpc-1293	30	19	a	a	DET
dpc-1293	30	20	6	6	NUM
dpc-1293	30	21	-	-	PUNCT
dpc-1293	30	22	year	year	NOUN
dpc-1293	30	23	history	history	NOUN
dpc-1293	30	24	of	of	ADP
dpc-1293	30	25	asymptomatic	asymptomatic	NOUN
dpc-1293	30	26	,	,	PUNCT
dpc-1293	30	27	pigmented	pigment	VERB
dpc-1293	30	28	,	,	PUNCT
dpc-1293	30	29	2	2	NUM
dpc-1293	30	30	letter	letter	NOUN
dpc-1293	30	31	|	|	ADV
dpc-1293	30	32	dermatol	dermatol	ADJ
dpc-1293	30	33	pract	pract	NOUN
dpc-1293	30	34	concept	concept	NOUN
dpc-1293	30	35	.	.	PUNCT
dpc-1293	31	1	2021;11(2):e2021006	2021;11(2):e2021006	NUM
dpc-1293	31	2	hyperkeratotic	hyperkeratotic	ADJ
dpc-1293	31	3	papules	papule	NOUN
dpc-1293	31	4	and	and	CCONJ
dpc-1293	31	5	plaques	plaque	NOUN
dpc-1293	31	6	around	around	ADP
dpc-1293	31	7	the	the	DET
dpc-1293	31	8	neck	neck	NOUN
dpc-1293	31	9	and	and	CCONJ
dpc-1293	31	10	on	on	ADP
dpc-1293	31	11	the	the	DET
dpc-1293	31	12	trunk	trunk	NOUN
dpc-1293	31	13	(	(	PUNCT
dpc-1293	31	14	figure	figure	NOUN
dpc-1293	31	15	3a	3a	NUM
dpc-1293	31	16	)	)	PUNCT
dpc-1293	31	17	.	.	PUNCT
dpc-1293	32	1	histological	histological	ADJ
dpc-1293	32	2	examination	examination	NOUN
dpc-1293	32	3	revealed	reveal	VERB
dpc-1293	32	4	orthohyperkeratosis	orthohyperkeratosis	NOUN
dpc-1293	32	5	,	,	PUNCT
dpc-1293	32	6	acanthosis	acanthosis	NOUN
dpc-1293	32	7	,	,	PUNCT
dpc-1293	32	8	and	and	CCONJ
dpc-1293	32	9	papillomatosis	papillomatosis	NOUN
dpc-1293	32	10	associated	associate	VERB
dpc-1293	32	11	with	with	ADP
dpc-1293	32	12	a	a	DET
dpc-1293	32	13	normal	normal	ADJ
dpc-1293	32	14	dermis	dermis	NOUN
dpc-1293	32	15	.	.	PUNCT
dpc-1293	33	1	a	a	DET
dpc-1293	33	2	diagnosis	diagnosis	NOUN
dpc-1293	33	3	of	of	ADP
dpc-1293	33	4	crp	crp	NOUN
dpc-1293	33	5	was	be	AUX
dpc-1293	33	6	made	make	VERB
dpc-1293	33	7	and	and	CCONJ
dpc-1293	33	8	the	the	DET
dpc-1293	33	9	patient	patient	NOUN
dpc-1293	33	10	was	be	AUX
dpc-1293	33	11	started	start	VERB
dpc-1293	33	12	on	on	ADP
dpc-1293	33	13	doxycycline	doxycycline	NOUN
dpc-1293	33	14	(	(	PUNCT
dpc-1293	33	15	100	100	NUM
dpc-1293	33	16	mg	mg	NUM
dpc-1293	33	17	/	/	SYM
dpc-1293	33	18	day	day	NOUN
dpc-1293	33	19	)	)	PUNCT
dpc-1293	33	20	,	,	PUNCT
dpc-1293	33	21	with	with	ADP
dpc-1293	33	22	complete	complete	ADJ
dpc-1293	33	23	clearance	clearance	NOUN
dpc-1293	33	24	of	of	ADP
dpc-1293	33	25	lesions	lesion	NOUN
dpc-1293	33	26	in	in	ADP
dpc-1293	33	27	2	2	NUM
dpc-1293	33	28	months	month	NOUN
dpc-1293	33	29	(	(	PUNCT
dpc-1293	33	30	figure	figure	NOUN
dpc-1293	33	31	3b	3b	NUM
dpc-1293	33	32	)	)	PUNCT
dpc-1293	33	33	.	.	PUNCT
dpc-1293	34	1	however	however	ADV
dpc-1293	34	2	,	,	PUNCT
dpc-1293	34	3	the	the	DET
dpc-1293	34	4	patient	patient	NOUN
dpc-1293	34	5	was	be	AUX
dpc-1293	34	6	lost	lose	VERB
dpc-1293	34	7	to	to	PART
dpc-1293	34	8	follow	follow	VERB
dpc-1293	34	9	-	-	PUNCT
dpc-1293	34	10	up	up	NOUN
dpc-1293	34	11	.	.	PUNCT
dpc-1293	35	1	conclusions	conclusion	NOUN
dpc-1293	35	2	crp	crp	PROPN
dpc-1293	35	3	is	be	AUX
dpc-1293	35	4	a	a	DET
dpc-1293	35	5	rare	rare	ADJ
dpc-1293	35	6	dermatosis	dermatosis	NOUN
dpc-1293	35	7	that	that	PRON
dpc-1293	35	8	affects	affect	VERB
dpc-1293	35	9	young	young	ADJ
dpc-1293	35	10	adults	adult	NOUN
dpc-1293	35	11	.	.	PUNCT
dpc-1293	36	1	clinically	clinically	ADV
dpc-1293	36	2	,	,	PUNCT
dpc-1293	36	3	the	the	DET
dpc-1293	36	4	eruption	eruption	NOUN
dpc-1293	36	5	is	be	AUX
dpc-1293	36	6	characterized	characterize	VERB
dpc-1293	36	7	by	by	ADP
dpc-1293	36	8	the	the	DET
dpc-1293	36	9	presence	presence	NOUN
dpc-1293	36	10	of	of	ADP
dpc-1293	36	11	pigmented	pigment	VERB
dpc-1293	36	12	hyperkeratotic	hyperkeratotic	ADJ
dpc-1293	36	13	papules	papule	NOUN
dpc-1293	36	14	and	and	CCONJ
dpc-1293	36	15	plaques	plaque	NOUN
dpc-1293	36	16	generally	generally	ADV
dpc-1293	36	17	asymptomatic	asymptomatic	ADJ
dpc-1293	36	18	and	and	CCONJ
dpc-1293	36	19	confluent	confluent	ADJ
dpc-1293	36	20	in	in	ADP
dpc-1293	36	21	the	the	DET
dpc-1293	36	22	center	center	NOUN
dpc-1293	36	23	with	with	ADP
dpc-1293	36	24	reticular	reticular	ADJ
dpc-1293	36	25	pattern	pattern	NOUN
dpc-1293	36	26	at	at	ADP
dpc-1293	36	27	the	the	DET
dpc-1293	36	28	periphery	periphery	NOUN
dpc-1293	36	29	[	[	X
dpc-1293	36	30	1	1	NUM
dpc-1293	36	31	]	]	PUNCT
dpc-1293	36	32	.	.	PUNCT
dpc-1293	37	1	the	the	DET
dpc-1293	37	2	lesions	lesion	NOUN
dpc-1293	37	3	are	be	AUX
dpc-1293	37	4	typically	typically	ADV
dpc-1293	37	5	localized	localize	VERB
dpc-1293	37	6	to	to	ADP
dpc-1293	37	7	the	the	DET
dpc-1293	37	8	trunk	trunk	NOUN
dpc-1293	37	9	.	.	PUNCT
dpc-1293	38	1	the	the	DET
dpc-1293	38	2	pathogenesis	pathogenesis	NOUN
dpc-1293	38	3	of	of	ADP
dpc-1293	38	4	crp	crp	PROPN
dpc-1293	38	5	remains	remain	VERB
dpc-1293	38	6	uncertain	uncertain	ADJ
dpc-1293	38	7	[	[	X
dpc-1293	38	8	1,2	1,2	NUM
dpc-1293	38	9	]	]	PUNCT
dpc-1293	38	10	.	.	PUNCT
dpc-1293	39	1	some	some	DET
dpc-1293	39	2	theories	theory	NOUN
dpc-1293	39	3	have	have	AUX
dpc-1293	39	4	suggested	suggest	VERB
dpc-1293	39	5	a	a	DET
dpc-1293	39	6	disorder	disorder	NOUN
dpc-1293	39	7	of	of	ADP
dpc-1293	39	8	keratinization	keratinization	NOUN
dpc-1293	39	9	,	,	PUNCT
dpc-1293	39	10	an	an	DET
dpc-1293	39	11	involvement	involvement	NOUN
dpc-1293	39	12	of	of	ADP
dpc-1293	39	13	bacterial	bacterial	ADJ
dpc-1293	39	14	pathogens	pathogen	NOUN
dpc-1293	39	15	via	via	ADP
dpc-1293	39	16	an	an	DET
dpc-1293	39	17	alteration	alteration	NOUN
dpc-1293	39	18	of	of	ADP
dpc-1293	39	19	sebum	sebum	NOUN
dpc-1293	39	20	,	,	PUNCT
dpc-1293	39	21	or	or	CCONJ
dpc-1293	39	22	an	an	DET
dpc-1293	39	23	abnormal	abnormal	ADJ
dpc-1293	39	24	response	response	NOUN
dpc-1293	39	25	to	to	ADP
dpc-1293	39	26	host	host	NOUN
dpc-1293	39	27	bacteria	bacteria	NOUN
dpc-1293	39	28	.	.	PUNCT
dpc-1293	40	1	another	another	DET
dpc-1293	40	2	hypothesis	hypothesis	NOUN
dpc-1293	40	3	is	be	AUX
dpc-1293	40	4	endocrine	endocrine	ADJ
dpc-1293	40	5	disturbance	disturbance	NOUN
dpc-1293	40	6	based	base	VERB
dpc-1293	40	7	on	on	ADP
dpc-1293	40	8	an	an	DET
dpc-1293	40	9	association	association	NOUN
dpc-1293	40	10	of	of	ADP
dpc-1293	40	11	crp	crp	PROPN
dpc-1293	40	12	with	with	ADP
dpc-1293	40	13	obesity	obesity	NOUN
dpc-1293	40	14	,	,	PUNCT
dpc-1293	40	15	insulin	insulin	NOUN
dpc-1293	40	16	resistance	resistance	NOUN
dpc-1293	40	17	,	,	PUNCT
dpc-1293	40	18	diabetes	diabetes	NOUN
dpc-1293	40	19	mellitus	mellitus	NOUN
dpc-1293	40	20	,	,	PUNCT
dpc-1293	40	21	and	and	CCONJ
dpc-1293	40	22	other	other	ADJ
dpc-1293	40	23	disorders	disorder	NOUN
dpc-1293	40	24	of	of	ADP
dpc-1293	40	25	the	the	DET
dpc-1293	40	26	thyroid	thyroid	NOUN
dpc-1293	40	27	and	and	CCONJ
dpc-1293	40	28	pituitary	pituitary	ADJ
dpc-1293	40	29	glands	gland	NOUN
dpc-1293	40	30	.	.	PUNCT
dpc-1293	41	1	to	to	ADP
dpc-1293	41	2	date	date	NOUN
dpc-1293	41	3	,	,	PUNCT
dpc-1293	41	4	only	only	ADV
dpc-1293	41	5	10	10	NUM
dpc-1293	41	6	cases	case	NOUN
dpc-1293	41	7	of	of	ADP
dpc-1293	41	8	crp	crp	NOUN
dpc-1293	41	9	associated	associate	VERB
dpc-1293	41	10	with	with	ADP
dpc-1293	41	11	obesity	obesity	NOUN
dpc-1293	41	12	(	(	PUNCT
dpc-1293	41	13	including	include	VERB
dpc-1293	41	14	the	the	DET
dpc-1293	41	15	presented	present	VERB
dpc-1293	41	16	cases	case	NOUN
dpc-1293	41	17	)	)	PUNCT
dpc-1293	41	18	have	have	AUX
dpc-1293	41	19	been	be	AUX
dpc-1293	41	20	reported	report	VERB
dpc-1293	41	21	in	in	ADP
dpc-1293	41	22	the	the	DET
dpc-1293	41	23	literature	literature	NOUN
dpc-1293	41	24	[	[	X
dpc-1293	41	25	2	2	NUM
dpc-1293	41	26	]	]	PUNCT
dpc-1293	41	27	.	.	PUNCT
dpc-1293	42	1	figure	figure	NOUN
dpc-1293	42	2	1	1	NUM
dpc-1293	42	3	.	.	PUNCT
dpc-1293	43	1	(	(	PUNCT
dpc-1293	43	2	a	a	X
dpc-1293	43	3	)	)	PUNCT
dpc-1293	43	4	brownish	brownish	ADJ
dpc-1293	43	5	,	,	PUNCT
dpc-1293	43	6	confluent	confluent	ADJ
dpc-1293	43	7	papules	papule	NOUN
dpc-1293	43	8	with	with	ADP
dpc-1293	43	9	a	a	DET
dpc-1293	43	10	slightly	slightly	ADV
dpc-1293	43	11	hyperkeratotic	hyperkeratotic	ADJ
dpc-1293	43	12	surface	surface	NOUN
dpc-1293	43	13	that	that	PRON
dpc-1293	43	14	affected	affect	VERB
dpc-1293	43	15	mainly	mainly	ADV
dpc-1293	43	16	the	the	DET
dpc-1293	43	17	trunk	trunk	NOUN
dpc-1293	43	18	.	.	PUNCT
dpc-1293	44	1	(	(	PUNCT
dpc-1293	44	2	b	b	X
dpc-1293	44	3	)	)	PUNCT
dpc-1293	44	4	complete	complete	ADJ
dpc-1293	44	5	clearance	clearance	NOUN
dpc-1293	44	6	of	of	ADP
dpc-1293	44	7	the	the	DET
dpc-1293	44	8	eruption	eruption	NOUN
dpc-1293	44	9	after	after	ADP
dpc-1293	44	10	2	2	NUM
dpc-1293	44	11	months	month	NOUN
dpc-1293	44	12	of	of	ADP
dpc-1293	44	13	treatment	treatment	NOUN
dpc-1293	44	14	with	with	ADP
dpc-1293	44	15	doxycycline	doxycycline	NOUN
dpc-1293	44	16	.	.	PUNCT
dpc-1293	45	1	figure	figure	NOUN
dpc-1293	45	2	2	2	NUM
dpc-1293	45	3	.	.	PUNCT
dpc-1293	46	1	(	(	PUNCT
dpc-1293	46	2	a	a	X
dpc-1293	46	3	)	)	PUNCT
dpc-1293	46	4	asymptomatic	asymptomatic	ADJ
dpc-1293	46	5	hyperpigmented	hyperpigmente	VERB
dpc-1293	46	6	papules	papule	NOUN
dpc-1293	46	7	and	and	CCONJ
dpc-1293	46	8	plaques	plaque	NOUN
dpc-1293	46	9	with	with	ADP
dpc-1293	46	10	a	a	DET
dpc-1293	46	11	reticulated	reticulated	ADJ
dpc-1293	46	12	pattern	pattern	NOUN
dpc-1293	46	13	.	.	PUNCT
dpc-1293	47	1	(	(	PUNCT
dpc-1293	47	2	b	b	X
dpc-1293	47	3	)	)	PUNCT
dpc-1293	47	4	complete	complete	ADJ
dpc-1293	47	5	resolution	resolution	NOUN
dpc-1293	47	6	of	of	ADP
dpc-1293	47	7	lesions	lesion	NOUN
dpc-1293	47	8	within	within	ADP
dpc-1293	47	9	1	1	NUM
dpc-1293	47	10	month	month	NOUN
dpc-1293	47	11	of	of	ADP
dpc-1293	47	12	doxycycline	doxycycline	NOUN
dpc-1293	47	13	treatment	treatment	NOUN
dpc-1293	47	14	.	.	PUNCT
dpc-1293	48	1	letter	letter	NOUN
dpc-1293	49	1	|	|	ADV
dpc-1293	49	2	dermatol	dermatol	ADJ
dpc-1293	49	3	pract	pract	NOUN
dpc-1293	49	4	concept	concept	NOUN
dpc-1293	49	5	.	.	PUNCT
dpc-1293	50	1	2021;11(2):e2021006	2021;11(2):e2021006	NUM
dpc-1293	50	2	3	3	NUM
dpc-1293	50	3	a	a	DET
dpc-1293	50	4	 	 	SPACE
dpc-1293	50	5	pathogenic	pathogenic	ADJ
dpc-1293	50	6	link	link	NOUN
dpc-1293	50	7	between	between	ADP
dpc-1293	50	8	these	these	DET
dpc-1293	50	9	2	2	NUM
dpc-1293	50	10	conditions	condition	NOUN
dpc-1293	50	11	is	be	AUX
dpc-1293	50	12	suggested	suggest	VERB
dpc-1293	50	13	by	by	ADP
dpc-1293	50	14	the	the	DET
dpc-1293	50	15	insulin	insulin	NOUN
dpc-1293	50	16	resistance	resistance	NOUN
dpc-1293	50	17	and	and	CCONJ
dpc-1293	50	18	the	the	DET
dpc-1293	50	19	resulting	result	VERB
dpc-1293	50	20	hyperinsulinemia	hyperinsulinemia	NOUN
dpc-1293	50	21	in	in	ADP
dpc-1293	50	22	obese	obese	ADJ
dpc-1293	50	23	patients	patient	NOUN
dpc-1293	50	24	.	.	PUNCT
dpc-1293	51	1	high	high	ADJ
dpc-1293	51	2	circulating	circulate	VERB
dpc-1293	51	3	insulin	insulin	NOUN
dpc-1293	51	4	levels	level	NOUN
dpc-1293	51	5	have	have	VERB
dpc-1293	51	6	mitogenic	mitogenic	ADJ
dpc-1293	51	7	and	and	CCONJ
dpc-1293	51	8	anti	anti	ADJ
dpc-1293	51	9	-	-	ADJ
dpc-1293	51	10	apoptotic	apoptotic	ADJ
dpc-1293	51	11	activities	activity	NOUN
dpc-1293	51	12	on	on	ADP
dpc-1293	51	13	keratinocytes	keratinocyte	NOUN
dpc-1293	51	14	[	[	X
dpc-1293	51	15	2	2	NUM
dpc-1293	51	16	]	]	PUNCT
dpc-1293	51	17	.	.	PUNCT
dpc-1293	52	1	these	these	DET
dpc-1293	52	2	activities	activity	NOUN
dpc-1293	52	3	may	may	AUX
dpc-1293	52	4	provide	provide	VERB
dpc-1293	52	5	an	an	DET
dpc-1293	52	6	explanation	explanation	NOUN
dpc-1293	52	7	for	for	ADP
dpc-1293	52	8	the	the	DET
dpc-1293	52	9	epidermal	epidermal	ADJ
dpc-1293	52	10	overgrowth	overgrowth	NOUN
dpc-1293	52	11	and	and	CCONJ
dpc-1293	52	12	papillomatosis	papillomatosis	NOUN
dpc-1293	52	13	seen	see	VERB
dpc-1293	52	14	in	in	ADP
dpc-1293	52	15	our	our	PRON
dpc-1293	52	16	patients	patient	NOUN
dpc-1293	52	17	.	.	PUNCT
dpc-1293	53	1	concerning	concern	VERB
dpc-1293	53	2	treatment	treatment	NOUN
dpc-1293	53	3	,	,	PUNCT
dpc-1293	53	4	various	various	ADJ
dpc-1293	53	5	modalities	modality	NOUN
dpc-1293	53	6	,	,	PUNCT
dpc-1293	53	7	mostly	mostly	ADV
dpc-1293	53	8	antibiotics	antibiotic	NOUN
dpc-1293	53	9	,	,	PUNCT
dpc-1293	53	10	have	have	AUX
dpc-1293	53	11	been	be	AUX
dpc-1293	53	12	proposed	propose	VERB
dpc-1293	53	13	with	with	ADP
dpc-1293	53	14	variable	variable	ADJ
dpc-1293	53	15	responses	response	NOUN
dpc-1293	53	16	[	[	X
dpc-1293	53	17	1	1	NUM
dpc-1293	53	18	]	]	PUNCT
dpc-1293	53	19	.	.	PUNCT
dpc-1293	54	1	complete	complete	ADJ
dpc-1293	54	2	resolution	resolution	NOUN
dpc-1293	54	3	with	with	ADP
dpc-1293	54	4	doxycycline	doxycycline	NOUN
dpc-1293	54	5	in	in	ADP
dpc-1293	54	6	our	our	PRON
dpc-1293	54	7	cases	case	NOUN
dpc-1293	54	8	further	far	ADV
dpc-1293	54	9	support	support	NOUN
dpc-1293	54	10	cyclins	cyclin	NOUN
dpc-1293	54	11	,	,	PUNCT
dpc-1293	54	12	safe	safe	ADJ
dpc-1293	54	13	and	and	CCONJ
dpc-1293	54	14	effective	effective	ADJ
dpc-1293	54	15	agents	agent	NOUN
dpc-1293	54	16	,	,	PUNCT
dpc-1293	54	17	as	as	ADP
dpc-1293	54	18	the	the	DET
dpc-1293	54	19	treatment	treatment	NOUN
dpc-1293	54	20	of	of	ADP
dpc-1293	54	21	choice	choice	NOUN
dpc-1293	54	22	for	for	ADP
dpc-1293	54	23	crp	crp	PROPN
dpc-1293	54	24	.	.	PUNCT
dpc-1293	55	1	their	their	PRON
dpc-1293	55	2	effectiveness	effectiveness	NOUN
dpc-1293	55	3	is	be	AUX
dpc-1293	55	4	mainly	mainly	ADV
dpc-1293	55	5	attributed	attribute	VERB
dpc-1293	55	6	to	to	ADP
dpc-1293	55	7	their	their	PRON
dpc-1293	55	8	anti	anti	ADJ
dpc-1293	55	9	-	-	ADJ
dpc-1293	55	10	inflammatory	inflammatory	ADJ
dpc-1293	55	11	properties	property	NOUN
dpc-1293	55	12	,	,	PUNCT
dpc-1293	55	13	most	most	ADV
dpc-1293	55	14	probably	probably	ADV
dpc-1293	55	15	attributed	attribute	VERB
dpc-1293	55	16	to	to	ADP
dpc-1293	55	17	inhibiting	inhibit	VERB
dpc-1293	55	18	neutrophil	neutrophil	ADJ
dpc-1293	55	19	migration	migration	NOUN
dpc-1293	55	20	and	and	CCONJ
dpc-1293	55	21	subsequent	subsequent	ADJ
dpc-1293	55	22	reactive	reactive	ADJ
dpc-1293	55	23	oxygen	oxygen	NOUN
dpc-1293	55	24	species	specie	NOUN
dpc-1293	55	25	release	release	NOUN
dpc-1293	55	26	that	that	PRON
dpc-1293	55	27	inhibit	inhibit	VERB
dpc-1293	55	28	matrix	matrix	NOUN
dpc-1293	55	29	metalloproteinases	metalloproteinase	NOUN
dpc-1293	55	30	,	,	PUNCT
dpc-1293	55	31	rather	rather	ADV
dpc-1293	55	32	than	than	ADP
dpc-1293	55	33	antimicrobial	antimicrobial	ADJ
dpc-1293	55	34	effects	effect	NOUN
dpc-1293	55	35	alone	alone	ADV
dpc-1293	55	36	.	.	PUNCT
dpc-1293	56	1	references	reference	NOUN
dpc-1293	56	2	1	1	NUM
dpc-1293	56	3	.	.	PUNCT
dpc-1293	57	1	lim	lim	PROPN
dpc-1293	57	2	jhl	jhl	PROPN
dpc-1293	57	3	,	,	PUNCT
dpc-1293	57	4	tey	tey	PROPN
dpc-1293	57	5	hl	hl	NOUN
dpc-1293	57	6	,	,	PUNCT
dpc-1293	57	7	chong	chong	PROPN
dpc-1293	57	8	ws	ws	PROPN
dpc-1293	57	9	.	.	PUNCT
dpc-1293	57	10	confluent	confluent	ADJ
dpc-1293	57	11	and	and	CCONJ
dpc-1293	57	12	reticulated	reticulated	ADJ
dpc-1293	57	13	papillomatosis	papillomatosis	NOUN
dpc-1293	57	14	:	:	PUNCT
dpc-1293	57	15	diagnostic	diagnostic	ADJ
dpc-1293	57	16	and	and	CCONJ
dpc-1293	57	17	treatment	treatment	NOUN
dpc-1293	57	18	challenges	challenge	NOUN
dpc-1293	57	19	.	.	PUNCT
dpc-1293	57	20	 	 	SPACE
dpc-1293	58	1	clin	clin	PROPN
dpc-1293	58	2	cosmet	cosmet	PROPN
dpc-1293	58	3	investig	investig	NOUN
dpc-1293	58	4	dermatol	dermatol	NOUN
dpc-1293	58	5	.	.	PUNCT
dpc-1293	59	1	2016;9:217	2016;9:217	NUM
dpc-1293	59	2	-	-	SYM
dpc-1293	59	3	223	223	NUM
dpc-1293	59	4	.	.	PUNCT
dpc-1293	60	1	doi	doi	NOUN
dpc-1293	60	2	:	:	PUNCT
dpc-1293	60	3	10.2147	10.2147	NUM
dpc-1293	60	4	/	/	SYM
dpc-1293	60	5	ccid.s92051	ccid.s92051	NOUN
dpc-1293	60	6	.	.	PUNCT
dpc-1293	61	1	pmid	pmid	NOUN
dpc-1293	61	2	:	:	PUNCT
dpc-1293	61	3	27601929	27601929	NUM
dpc-1293	61	4	.	.	PUNCT
dpc-1293	62	1	2	2	X
dpc-1293	62	2	.	.	X
dpc-1293	62	3	fukumoto	fukumoto	PROPN
dpc-1293	62	4	t	t	PROPN
dpc-1293	62	5	,	,	PUNCT
dpc-1293	62	6	kozaru	kozaru	PROPN
dpc-1293	62	7	t	t	PROPN
dpc-1293	62	8	,	,	PUNCT
dpc-1293	62	9	sakaguchi	sakaguchi	PROPN
dpc-1293	62	10	m	m	PROPN
dpc-1293	62	11	,	,	PUNCT
dpc-1293	62	12	oka	oka	PROPN
dpc-1293	62	13	m.	m.	NOUN
dpc-1293	62	14	concomitant	concomitant	PROPN
dpc-1293	62	15	confluent	confluent	ADJ
dpc-1293	62	16	and	and	CCONJ
dpc-1293	62	17	reticulated	reticulated	ADJ
dpc-1293	62	18	papillomatosis	papillomatosis	NOUN
dpc-1293	62	19	and	and	CCONJ
dpc-1293	62	20	acanthosis	acanthosis	NOUN
dpc-1293	62	21	nigricans	nigrican	NOUN
dpc-1293	62	22	in	in	ADP
dpc-1293	62	23	an	an	DET
dpc-1293	62	24	obese	obese	ADJ
dpc-1293	62	25	girl	girl	NOUN
dpc-1293	62	26	with	with	ADP
dpc-1293	62	27	insulin	insulin	NOUN
dpc-1293	62	28	resistance	resistance	NOUN
dpc-1293	62	29	successfully	successfully	ADV
dpc-1293	62	30	treated	treat	VERB
dpc-1293	62	31	with	with	ADP
dpc-1293	62	32	oral	oral	ADJ
dpc-1293	62	33	minocycline	minocycline	NOUN
dpc-1293	62	34	:	:	PUNCT
dpc-1293	62	35	case	case	NOUN
dpc-1293	62	36	report	report	NOUN
dpc-1293	62	37	and	and	CCONJ
dpc-1293	62	38	published	publish	VERB
dpc-1293	62	39	work	work	NOUN
dpc-1293	62	40	review	review	NOUN
dpc-1293	62	41	.	.	PUNCT
dpc-1293	63	1	j	j	PROPN
dpc-1293	63	2	dermatol	dermatol	NOUN
dpc-1293	63	3	.	.	PUNCT
dpc-1293	64	1	2017;44(8):954	2017;44(8):954	NOUN
dpc-1293	64	2	-	-	SYM
dpc-1293	64	3	958	958	NUM
dpc-1293	64	4	.	.	PUNCT
dpc-1293	65	1	doi	doi	NOUN
dpc-1293	65	2	:	:	PUNCT
dpc-1293	65	3	10.1111/1346	10.1111/1346	NUM
dpc-1293	65	4	-	-	PUNCT
dpc-1293	65	5	8138.13819	8138.13819	NOUN
dpc-1293	65	6	.	.	PUNCT
dpc-1293	66	1	pmid	pmid	NOUN
dpc-1293	66	2	:	:	PUNCT
dpc-1293	66	3	28295566	28295566	NUM
dpc-1293	66	4	.	.	PUNCT
dpc-1293	67	1	figure	figure	NOUN
dpc-1293	67	2	3	3	NUM
dpc-1293	67	3	.	.	PUNCT
dpc-1293	68	1	(	(	PUNCT
dpc-1293	68	2	a	a	X
dpc-1293	68	3	)	)	PUNCT
dpc-1293	68	4	pigmented	pigmented	ADJ
dpc-1293	68	5	hyperkeratotic	hyperkeratotic	ADJ
dpc-1293	68	6	skin	skin	NOUN
dpc-1293	68	7	eruption	eruption	NOUN
dpc-1293	68	8	on	on	ADP
dpc-1293	68	9	the	the	DET
dpc-1293	68	10	trunk	trunk	NOUN
dpc-1293	68	11	particularly	particularly	ADV
dpc-1293	68	12	on	on	ADP
dpc-1293	68	13	the	the	DET
dpc-1293	68	14	intermammary	intermammary	ADJ
dpc-1293	68	15	region	region	NOUN
dpc-1293	68	16	.	.	PUNCT
dpc-1293	69	1	(	(	PUNCT
dpc-1293	69	2	b	b	X
dpc-1293	69	3	)	)	PUNCT
dpc-1293	69	4	complete	complete	ADJ
dpc-1293	69	5	clearance	clearance	NOUN
dpc-1293	69	6	of	of	ADP
dpc-1293	69	7	lesions	lesion	NOUN
dpc-1293	69	8	after	after	ADP
dpc-1293	69	9	2	2	NUM
dpc-1293	69	10	months	month	NOUN
dpc-1293	69	11	of	of	ADP
dpc-1293	69	12	doxycycline	doxycycline	NOUN
dpc-1293	69	13	.	.	PUNCT